Cargando…

Isolated Renal Calyceal Urothelial Carcinoma Effectively Treated With PD-1 Inhibitor Alone: A Case Report And Literature Review

The discovery of immune checkpoint inhibitors (ICIs) represents a significant step forward in the battle against malignant tumors. In a number of advanced malignancies, ICIs, such as antibodies to programmed cell death protein-1 inhibitor (PD-1) and its ligand, programmed death-ligand 1 (PD-L1), hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shihao, Zhu, Yi, Xu, Zhijian, Liu, Jianjun, Liu, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128378/ https://www.ncbi.nlm.nih.gov/pubmed/35619897 http://dx.doi.org/10.3389/fonc.2022.866013

Ejemplares similares

Case Report: A MiT family translocation renal cell carcinoma in the renal pelvis, calyces and upper ureter misdiagnosed as upper tract urothelial carcinoma
por: Zou, Yuhua, et al.
Publicado: (2023)

Safety and efficacy of superior calyceal access versus inferior calyceal access for pelvic and/or lower calyceal renal calculi- a prospective observational comparative study
por: Amaresh, M., et al.
Publicado: (2020)

Primary renal angiosarcoma mimicking urothelial carcinoma – A case report and literature reviews
por: Chang, Che-Wei, et al.
Publicado: (2020)

A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report
por: Wang, Jianzheng, et al.
Publicado: (2021)

A case report of renal calyceal diverticulum with hypertension in children and review of literature
por: Zhao, Yongxiang, et al.
Publicado: (2022)

Case report: Sarcomatoid urothelial carcinoma of the renal pelvis masquerading as a renal abscess
por: Chu, Yaru, et al.
Publicado: (2023)

Classification and clinical significance of the posterior group of renal calyces
por: Qi, Yucheng, et al.
Publicado: (2023)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

Laparoscopic calyceal diverticulectomy
por: Bonastre, Cristina, et al.
Publicado: (2016)

Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer
por: Zhai, Xiaoyang, et al.
Publicado: (2020)

PARP Inhibitors in Prostate and Urothelial Cancers
por: Garje, Rohan, et al.
Publicado: (2020)

Synchronous Renal Neoplasm: Clear Cell Renal Cell Carcinoma and Papillary Urothelial Carcinoma in the Same Kidney
por: Benavides-Huerto, Miguel Armando, et al.
Publicado: (2017)

Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma
por: Doshi, Gurjyot K., et al.
Publicado: (2023)

Milk of calcium in renal calyces, renal pelvis, and ureter in a person with tetraplegia
por: Subramanian, Vaidyanathan, et al.
Publicado: (2023)

Efficacy and safety of PD-1/PD-L1 inhibitor combined with chemotherapy versus chemotherapy alone in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
por: Liu, Bo-Wei, et al.
Publicado: (2023)

Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
por: Kuo, Ming-Chun, et al.
Publicado: (2020)

Papillary urothelial carcinoma of the vagina: A case presentation and review of the literature
por: Razdan, Shirin, et al.
Publicado: (2019)

HER2 expression in urothelial carcinoma, a systematic literature review
por: Scherrer, Emilie, et al.
Publicado: (2022)

Giant calyceal diverticulum with an extra-renal component: A case report
por: Romeiro Victor, David, et al.
Publicado: (2023)

Data on changes in renal calyceal pattern among renal donors using CT angiography
por: Kumaresan, M, et al.
Publicado: (2021)

Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors
por: Lavoie, Jean-Michel, et al.
Publicado: (2021)

High Grade Mucinous Urothelial Carcinoma of the Renal Collecting System: A Case Report
por: Kancherla, Priyanka, et al.
Publicado: (2017)

Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study
por: Qu, Shuping, et al.
Publicado: (2022)

The Prevalence and Prognostic Role of PD-L1 in Upper Tract Urothelial Carcinoma Patients Underwent Radical Nephroureterectomy: A Systematic Review and Meta-Analysis
por: Lu, Yi, et al.
Publicado: (2020)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis
por: Chan, Wai-Nga, et al.
Publicado: (2022)

Systematic Assessment of Risk of Fever in Solid Tumor Patients Treated With PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
por: Liu, Hongmei, et al.
Publicado: (2020)

Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021)

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort
por: Barata, Pedro, et al.
Publicado: (2020)

Renal Calyceal Rupture following Ureteral Injury after Total Laparoscopic Hysterectomy
por: Watrowski, Rafł, et al.
Publicado: (2020)

Superior calyceal access vs. other calyceal access in percutaneous nephrolithotomy: A systematic review and meta-analysis
por: Ma, Yucheng, et al.
Publicado: (2022)

Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review
por: Wan, Yuchen, et al.
Publicado: (2022)

Urothelial Cancer With Occult Bone Marrow Metastases and Isolated Thrombocytopenia
por: Alva, Ajjai, et al.
Publicado: (2015)

Inadvertent radical nephrectomy leads to worse prognosis in renal pelvic urothelial carcinoma patients: A propensity score-matched study
por: Wu, Feixiang, et al.
Publicado: (2022)

Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
por: Peng, Ye, et al.
Publicado: (2021)

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors
por: Li, Xingzhi, et al.
Publicado: (2023)

Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma
por: Akhavein, Arash, et al.
Publicado: (2014)

PD-1 inhibitor therapy causes multisystem immune adverse reactions: a case report and literature review
por: Yin, Na, et al.
Publicado: (2022)

Calyceal-venous fistula of the kidney: A rare case report and review of literature
por: Low, Li Sian, et al.
Publicado: (2018)

Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
por: Cheng, Pai-Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lsa03neg9cc04mjaor503kab6g